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bstract
The mammalian proton-coupled peptide transporter PepT1 is the major route of uptake for dietary nitrogen, as well as the oral
bsorption of a number of drugs, including -lactam antibiotics and angiotensin-converting enzyme inhibitors. Here we have used
ite-directed mutagenesis to investigate further the role of conserved charged residues in transmembrane domains. Mutation of
abbit PepT1 arginine282 (R282, transmembrane domain 7) to a positive (R282K) or physiologically titratable residue (R282H),
esulted in a transporter with wild-type characteristics when expressed in Xenopus laevis oocytes. Neutral (R282A, R282Q) or
egatively charged (R282D, R282E) substitutions gave a transporter that was not stimulated by external acidification (reducing
Hout from 7.4 to 5.5) but transported at the same rate as the wild-type maximal rate (pHout 5.5); however, only the R282E mutation
as unable to concentrate substrate above the extracellular level. All of the R282 mutants showed trans-stimulation of efflux
omparable to the wild-type, except R282E-PepT1 which was faster. A conserved negatively charged residue, aspartate341 (D341)
n transmembrane domain 8 was implicated in forming a charge pair with R282, as R282E/D341R- and R282D/D341R-PepT1 had
ild-type transporter characteristics. Despite their differences in ability to accumulate substrate, both R282E- and R282D-PepT1howed an increased charge:peptide stoichiometry over the wild-type 1:1 ratio for the neutral dipeptide Gly-l-Gln, measured using
wo-electrode voltage clamp. This extra charge movement was linked to substrate transport, as 4-aminobenzoic acid, which binds
ut is not translocated, did not induce membrane potential depolarisation in R282E-expressing oocytes. A model is proposed for
he substrate binding/translocation process in PepT1.
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tion; Pr
Open access under CC BY license.eywords: Epithelia; Membrane transport; SLC15a1; Nutrient absorp
. IntroductionThe proton-coupled di- and tri-peptide transporter
epT1 (SLC15a1) is the major route of uptake of
∗ Corresponding author at: School of Life Sciences, Oxford Brookes
niversity, Headington, Oxford OX3 OBP, UK. Tel.: +44 1865 483613.
E-mail address: dmeredith@brookes.ac.uk (D. Meredith).
1 School of Life Sciences, Oxford Brookes University, Headington,
xford OX3 OBP, UK.
357-2725 © 2007 Elsevier Ltd.
doi:10.1016/j.biocel.2007.10.010
Open access under CC BY license.otein structure–function; Site-directed mutagenesis
dietary nitrogen from the intestine, and is also impor-
tant along with the higher affinity gene product PepT2
(SLC15a2) in the re-absorption of filtered peptides in
the kidney (Daniel & Kottra, 2004; Meredith & Boyd,
2000). In addition, PepT1 is the route of entry of
a wide class of orally bio-available pharmaceutically
important compounds, including the -lactam antibi-
otics, angiotensin-converting enzyme (ACE) inhibitors,
antiviral and anticancer agents (Terada & Inui, 2004).
Although these therapeutic compounds are not di- or
f Bioch722 M. Pieri et al. / The International Journal o
tri-peptides, they are carried by virtue of their similar
3D shape to endogenous substrates, i.e. they are pep-
tidomimetic, and modelling of the substrate-binding site
from the features in common of this huge and diverse
range of substrates has led to predictions concerning
which parts of the PepT1 protein may be important. For
example, a substrate template model has been developed
by several groups (Bailey et al., 2000; Bailey et al., 2006;
Biegel et al., 2005) which allows prediction of binding
affinity for a potential substrate.
The rabbit PepT1 is a 707 amino acid protein, with
twelve transmembrane spanning domains (TMDs) as
confirmed by epitope mapping (Covitz, Amidon, &
Sadee, 1998). In the absence of a crystal structure,
attempts have been made to computer model the PepT1
transporter itself (Bolger et al., 1998), with site-directed
mutagenesis used to test hypotheses generated by these
models. One potential complication for these kind
of studies is our recent report that PepT1 may form
multimers in the plasma membrane (Panitsas, Boyd, &
Meredith, 2006) although it is not clear how the subunits
interact.
Site-directed mutagenesis has been a useful tool to
identify functionally important residues in PepT1. One
such residue is arginine282 in the rabbit PepT1 sequence.
The mutation of arginine282 to a glutamate produced a
peptide transporter (R282E-PepT1) that was no longer
driven by a proton-gradient but behaved more like a
facilitated peptide transporter, whilst simultaneously
exhibiting peptide-gated currents that were proposed
to be through a non-specific cation channel activity
(Meredith, 2004). Residue 282 is located approximately
halfway down the predicted transmembrane domain 7
(TMD7), and is either an arginine or a lysine in all cloned
mammalian PepT1 sequences to date. The presence of
a charged amino acid residue in a TMD, along with
its conservation, suggested a functional role. Here, we
have systematically investigated the role of arginine282
in rabbit PepT1 by making further mutations to deter-
mine the requirement for the charge and have identified
an interacting residue, aspartate341, located in puta-
tive TMD8. Some of these data have been previously
published in abstract form (Pieri, Boyd, & Meredith,
2004).
2. Materials and methods
2.1. Site-directed mutagenesis of the PepT1 geneOligonucleotides were custom synthesised (Sigma-
Genosys, UK) for the following sequences (residues in
bold are changed from wild-type PepT1):emistry & Cell Biology 40 (2008) 721–730
- R282-PepT1 mutants forward:
5’ CGCAGATCAAGATGGTTACGxxxGTGCTGTT
CCTGTACATCC 3’
where xxx was CAA for R282Q, AAG for R282K,
GAT for R282D, CAT for R282H, and GCG for
R282A.
- D341-PepT1 mutants forward:
5’ TCCTGGTCCCCATCATGxxxGCCGTGGTGTA
TCC 3’
where xxx was CGC for D341R.
Reverse primers for the PepT1 mutant PCR reactions
were the reverse compliment of the forward primers.
The site-directed PepT1 mutants were generated using
the Quikchange protocol (Stratagene), and the resulting
constructs confirmed by DNA sequencing (Department
of Biochemistry, University of Oxford, UK).
2.2. cRNA synthesis and oocyte injection
PepT1 constructs were linearised with XbaI (New
England Biolabs, UK) and cRNA generated by in vitro
transcription (T7 mMessage mMachine, Ambion, Cam-
bridgeshire, UK). X. laevis oocytes were obtained under
MS222 anaesthesia (0.2%, w/v) in accordance with
the UK Animals (Scientific Procedures) Act, 1986,
and maintained at 18 ◦C in modified Barth’s medium
(88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4, 2.4 mM
NaHCO3, 0.42 mM CaCl2, 10 mM Hepes, 5 mM sodium
pyruvate, 50g ml−1 gentamicin (Fluka, Poole, UK),
adjusted to pH 7.6 with 1 M NaOH). Transport measure-
ments were performed at least 72 h after micro-injection
of oocytes with 27nl cRNA (1g/l), with medium
changed daily.
2.3. Transport experiments
Zero-trans uptake of [3H]-d-Phe-l-Gln (17.4 Ci/
mmole, custom synthesised, Cambridge Research Bio-
chemicals, Stockton-on-Tees, UK) was performed
as previously described (Meredith, 2004). Briefly,
5 oocytes were incubated in 100l of uptake
medium (95 mM NaCl, 2 mM KCl, 1 mM CaCl2,
0.42 mM MgCl2, 10 mM Tris/Hepes pH 7.4 or
Tris/Mes pH 5.5) with tracer (0.4M) [3H]-d-Phe-
l-Gln. After incubation, the oocytes were washed
sequentially five times in 1 ml of ice-cold 120 mM
NaCl solution, lysed individually with 100l 2%
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control non-injected oocytes were also incu-
ated in uptake medium with [3H]-d-Phe-l-Gln as
bove.
The affinity of wild-type and mutant PepT1 were
ssessed by competition studies with 0.4M [3H]-d-
he-l-Gln and Gly-l-Gln present in the uptake medium
n concentrations from 0 to 2 mM using the protocol
bove, and the Ki calculated using the method of Deves
nd Boyd (1989).
Efflux studies were performed as previously
escribed (Meredith, 2004), with the exception that
he extracellular trans-stimulant Gly-l-Gln was used at
mM, and an efflux time-course was performed.
Diethylpyrocarbonate (DEPC) inhibition of PepT1
as performed using a similar protocol to that of Terada,
aito, and Inui (1998). Briefly, PepT1 oocytes were
reincubated with 1 mM DEPC for 15 min at pHout
.5 in the absence or presence of the PepT1 sub-
trates Gly-l-Gln, N-Acetyl-Phe (Meredith et al., 2000),
nd l-Ala-Tyramine (custom synthesised) and the non-
ubstrate Tyr (all 5 mM). The oocytes were then washed
n uptake medium before uptake assays were performed
s detailed above.
.4. Electrophysiology
Measurements of membrane potential were made by
mpaling oocytes with a single glass microelectrode
Intra 767 amplifier, WPI, Stevenage, Hertfordshire,
K) perfused in uptake medium (as above) with or
ithout 0.4M d-Phe-l-Gln (synthesised in house),
.6 mM Gly-l-Gln (Sigma, Poole, UK) or 10 mM 4-
ig. 1. pH dependence of initial rate [3H]-d-Phe-l-Gln uptake by
enopus oocytes expressing R282 mutants of rabbit PepT1, expressed
s -fold stimulation by extracellular acidification (pHout 7.4 to 5.5),
he dotted line showing where there is no stimulation (n≥ 3 oocyte
reparations with at least 5 oocytes per data point for each, except
or R282Q-PepT1 where n = 2; *p < 0.05 for stimulation by external
cidification, one-way ANOVA).emistry & Cell Biology 40 (2008) 721–730 723
aminobenzoic acid (4-AMBA, Sigma). Two-electrode
voltage clamp (TEVC) was performed by placing
oocytes in a 0.1 ml recording chamber and perfusing with
uptake solution (pH 5.5 or 7.4) at a rate of 15 ml/min.
Oocytes were impaled by two agarose-cushioned micro-
electrodes filled with 3 M KCl (0.5–2.0 M) and
voltage-clamped at −60 mV using a Geneclamp 500B
amplifier and PCLAMP 8.1 software (Axon Instru-
ments, CA, USA). The holding potential was stepped
from −60 mV over the range of −150 to +50 mV in
10 mV steps, each pulse lasting 100 ms, and returning
to −60 mV in between test voltage pulses. Typically
traces were filtered at 1 kHz during recording and dig-
itized at 0.5–5 kHz using the DigiData 1200 interface
(Axon Instruments, CA, USA). All experiments were
carried out at room temperature.
2.5. Data analysis
All data are expressed as mean ± S.E.M., except for
Fig. 6 where the error bars represent the maximum range
of stoichiometry values when taking into account the
errors for the uptake data and the currents.
In order to calculate the apparent charge:substrate
stoichiometry, the peptide induced current that was mea-
sured by two-electrode voltage clamp at the oocyte
resting membrane potential was divided by the radi-
olabelled dipeptide uptake in oocytes from the same
preparation. This value was normalised to 1:1 for wild-
type PepT1, the accepted stoichiometry for a neutral
dipeptide (Fei et al., 1994; Steel et al., 1997).
2.6. Statistical analysis
Statistical analyses were performed using one-way
ANOVA with differences considered significant if
p < 0.05 when data were compared to the wild-type con-
trol, as detailed in the text and/or figure legend.
3. Results
3.1. pH dependence of d-Phe-l-Gln uptake into
R282 mutants
Fig. 1 shows the pH dependence of d-Phe-l-Gln
uptake into oocytes expressing mutant PepT1 trans-
porters where R282 has been changed into number of
amino acid residues. Of the residues tested, R282K-
and R282H-PepT1 behaved like the wild-type PepT1,
in that the initial rate of uptake (1 h incubation time)
of dipeptide was significantly faster (p < 0.05, one-way
ANOVA) at an external pH of 5.5 than at 7.4. The
724 M. Pieri et al. / The International Journal of Bioch
Fig. 2. Inhibition of [3H]-d-Phe-l-Gln uptake by increasing concen-
trations of Gly-l-Gln (0–1 mM) into Xenopus oocytes expressing
either the various R282 mutants or wild-type PepT1 at pHout 5.5.
Ki values were wild-type PepT1 0.39 ± 0.22, R282E 0.35 ± 0.17,
R282K 0.48 ± 0.26, R282D 0.34 ± 0.27, R282A 0.30 ± 0.17, R282Q
0.46 ± 0.22 and R282H 0.30 ± 0.15 mM. n = 5 oocytes per data point.
Fig. 3. Accumulation of [3H]-d-Phe-l-Gln above the extracellular concentra
Fig. 3a and b shows representative time-course experiments at pHout 5.5 and 7
5.5 and 7.4 after 8 h incubation, respectively. The dotted line represents the
(*p < 0.05, one-way ANOVA). For R282E-PepT1 at pHout 7.4, the same leve
p > 0.05, one-way ANOVA, n = 5 oocyte preparations with 5 oocytes per data
3 for further details). NI = non-injected control oocytes.emistry & Cell Biology 40 (2008) 721–730
other amino acid substitutions tested, R282E- (as previ-
ously reported, Meredith, 2004), R282D-, R282A- and
R282Q-PepT1 all gave the same initial rate of uptake at
pH 5.5 and 7.4, indicating that transport by these mutants
is not stimulated by an inwardly directed proton gradient.
These changes cannot be ascribed to changes in the affin-
ity of the mutant PepT1 proteins for their substrate, as
the Ki of Gly-l-Gln inhibiting 0.4M [3H]-d-Phe-l-Gln
was unchanged in the mutants (Fig. 2).
3.2. Can the R282 mutant PepT1 transporters
concentrate substrates?
An earlier finding was that, unlike the wild-type, the
R282E-PepT1 mutant was unable to concentrate sub-
strate even in the presence of an inwardly directed proton
gradient (Meredith, 2004). The ability to concentrate
substrate was therefore tested for the other R282 mutants
(Fig. 3a and b shows representative time-course experi-
tion by Xenopus oocytes expressing R282 mutants of rabbit PepT1.
.4, respectively. Fig. 3c and d shows the accumulation ratios at pHout
equilibrium value if the volume of an oocyte is assumed to be 1l
l of accumulation was reached after 24 h incubation (2.3 ± 0.4-fold,
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ents at pHout 5.5 and 7.4, respectively), and the mean
ccumulation levels are shown for 8 h uptakes in Fig. 3c
or pHout 5.5. In contrast to R282E-PepT1, all were found
o be able to concentrate peptide well above the equilib-
ium level when the external pH was 5.5 (an oocyte was
ssumed to have a volume of 1l, Petersen & Berridge,
996; Yao & Tsien, 1997). In the absence of the proton
riving force (pHout 7.4, Fig. 3d) a similar level of intra-
ellular d-Phe-l-Gln concentration was reached by all
he mutant PepT1 transporters, including R282E-PepT1
f the incubation time was increased to 24 h (accumu-
ation of 2.3 ± 0.4-fold compared to 3.1 ± 0.5-fold for
ild-type PepT1). Although at 24 h incubation times we
bserved that cell survival can be a limiting factor, there
as no statistical increase in the accumulation for the
ild-type PepT1 at pHout 5.5 or 7.4 between 8 and 24 h
ncubations, nor between 8 and 24 h for the wild-type
epT1 at pHout 7.4 (8.0 ± 1.4 vs. 8.3 ± 1.0, 2.5 ± 0.5
s. 3.1 ± 0.5 and 1.0 ± 0.4 vs. 1.5 ± 0.3 respectively, all
> 0.05, one-way ANOVA).
.3. Rates of d-Phe-l-Gln efﬂux from R282 mutants
Fig. 4 shows the rates of efflux of [3H]-d-Phe-l-Gln
rom oocytes expressing either wild-type PepT1, R282
epT1 mutants or non-injected controls. All of the PepT1
onstructs showed a significantly faster efflux than
he non-injected oocytes (one-way ANOVA, p < 0.05),
ig. 4. Efflux of intracellular [3H]-d-Phe-l-Gln in the presence of
mM Gly-l-Gln expressed as a fraction of that seen in the absence of
rans-stimulant for non-injected control oocytes (NI), wild-type and
282 mutant PepT1 expressing Xenopus oocytes. Efflux by R282E-
epT1 at 30 min was significantly faster than for the wild-type and
ther R282 mutant PepT1s (*p < 0.05, one-way ANOVA), whilst efflux
rom all of the PepT1 expressing oocytes was faster than that for
on-injected. After 60 min, the effluxes from all the PepT1 expressing
ocytes were not significantly different, whilst significantly faster than
or non-injected controls (p < 0.05, one-way ANOVA). n = 5 oocytes
er data point.emistry & Cell Biology 40 (2008) 721–730 725
whilst R282E-PepT1 was significantly faster than the
wild-type (one-way ANOVA, p < 0.05) as previously
described (Meredith, 2004). Interestingly, R282E-PepT1
showed a faster efflux than all the other R282 mutants
(one-way ANOVA, p < 0.05), which were not signifi-
cantly different to the wild-type (p = 0.14).
3.4. Apparent transport stoichiometry (charge to
substrate) using two-electrode voltage clamp
As well as uptake being pH independent and non-
concentrative, the electrophysiological characteristics of
R282E-PepT1 were strikingly different to the wild-type
(Meredith, 2004). Since R282D-PepT1 is similarly pH
independent but does accumulate substrate, the apparent
proton to peptide stoichiometry was examined, where
the uptake of 0.4M d-Phe-l-Gln was compared to the
peptide-induced current in the same batch of oocytes.
The current at the oocyte resting membrane potential
(−27.0 ± 1.1 mV at pHout 5.5, and −36.8 ± 2.2 mV at
pHout 7.4, n = 12) was taken to represent the membrane
potential under uptake conditions, as the addition of
0.4M substrate does not produce a detectable change in
membrane potential (Fig. 5). The ratio of proton to neu-
tral dipeptide co-transported through wild-type PepT1 is
1:1 (Fei et al., 1994; Steel et al., 1997), yet in R282E-,
R282D- and R282A-PepT1 the apparent stoichiometry
is substantially higher (4, 5 and 5 respectively at pHout
5.5, Fig. 6).
3.5. Is the extra current measured dependent on
substrate transport?
In an attempt to see if the extra current car-
ried by R282E-PepT1 was dependent on substrate
translocation rather than simply substrate binding, the
non-translocated PepT1 substrate 4-aminobenzoic acid
(4-AMBA, Darcel, Liou, Tome, & Raybould, 2005;
Meredith et al., 1998) was used. As found for wild-
type PepT1, 4-AMBA failed to induce a depolarisation
in R282E-PepT1 oocytes at 10 mM, three times its
Ki (Meredith et al., 2000), in contrast to the known
transported substrate Gly-l-Gln, also at three times Ki
(Fig. 5).
3.6. Identiﬁcation of an interacting residue for R282
The conservation of a positively charged amino acid
in a transmembrane domain (TMD7), and the results
above, strongly suggested that the presence of a pos-
itive charged residue was necessary for wild-type-like
PepT1 transport function. In TMD8, predicted to be
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Fig. 5. Representative trace of membrane potential from an oocyte
expressing wild-type PepT1 (Fig. 5a) or R282E-PepT1 (Fig. 5b) in
Fig. 6. Charge:peptide stoichiometry of uptake of Gly-l-Gln in Xeno-
pus oocytes expressing R282E-, R282D- or R282A-PepT1, normalised
to that of the wild-type PepT1 being 1:1 as previously reported (Fei et
al., 1994; Steel et al., 1997). The average error on the current measure-
ments was 13 ± 3.8% (n = 3 oocytes per mutant) and on the uptakes
nus (l-Ala-Tyramine) only partially prevented DEPC
inhibition (Fig. 8).
Fig. 7. pH dependence of initial rate [3H]-d-Phe-l-Gln uptake intothe absence or presence of Gly-l-Gln, d-Phe-l-Gln and 4-AMBA
(0.6 mM, 0.4M and 10 mM respectively, for 1 min each), at pHout 5.5.
Non-injected control oocytes showed no response (data not shown),
with similar responses seen for at least 3 oocytes.
at approximately the same level in the membrane,
there is a conserved aspartate (D341), and it was an
appealing hypothesis that the two oppositely charged
side chains might be forming a charge pair. To test
this, double mutants were made, R282E/D341R- and
R282D/D341R-PepT1, to swap the charges over. As can
be seen in Fig. 7, these double mutants showed the same
pH dependence of influx as the wild-type transporter,
providing strong evidence to support the hypothesis.
Both R282E/D341R- and R282D/D341R-PepT1 were
also able to concentrate substrate like the wild-type (data
not shown).
3.7. Diethylpyrocarbonate inhibition of PepT1
function
Preincubation of wild-type PepT1-expressing oocy-
tes with 1 mM diethylpyrocarbonate (DEPC) for 15 min4.4 ± 0.7% (n = 5 oocytes per mutant); the error bars on the figure rep-
resent the extremes of the stoichiometry that would be calculated using
these error values.
completely inhibited the PepT1 mediated dipeptide
uptake measured over 1 h, as shown in Fig. 8. This inhi-
bition by DEPC was largely prevented by the presence
of the known PepT1 substrates Gly-l-Gln and N-Acetyl-
Phe (Meredith et al., 2000), but not by the amino acid
non-substrate Tyr. Interestingly, despite being a good
PepT1 substrate (Ki approximately 0.1 mM, data not
shown), a modified peptide lacking a carboxyl termi-oocytes expressing wild-type, R282E-, D341R-, R282E/D341R- and
R282D/D341R-PepT1 expressed as -fold stimulation by extracellular
acidification (pHout 7.4–5.5), the dotted line showing where there is no
stimulation (*p < 0.05 for the -fold stimulation being greater than one,
one-way ANOVA, n≥ 3 oocyte preparations).
M. Pieri et al. / The International Journal of Bioch
Fig. 8. Protection of PepT1 from diethylpyrocarbonate (DEPC) inhibi-
tion (1 mM, 15 min incubation) by Gly-l-Gln (GlyGln), N-Acetyl-Phe
(AcPhe) and l-Ala-Tyramine, but not Tyr (all present at 5 mM dur-














tver 1 h. *p < 0.05 when compared to wild-type PepT1 (one-way
NOVA, 5 oocytes per data point, n = 3 oocyte preparations). NI = non-
njected control oocytes.
. Discussion
The R282K mutation of rabbit PepT1 is not only the
ost conservative one regarding the charge, but in a num-
er of species, including dog, rat and mouse, lysine is the
aturally occurring residue at this position. Therefore it
as not surprising to find that this mutant behaves like
he wild-type rabbit PepT1 (pig, sheep, rhesus and crab-
ating monkeys and human also have R282). The finding
hat R282H also behaved like the wild-type was interest-
ng, as histidine has a side-chain that can be titrated over
he range used in the experiments (pK of ∼6 in free solu-
ion). Our findings could be interpreted in several ways,emistry & Cell Biology 40 (2008) 721–730 727
including the possibility that only at pHout 5.5 is there
the formation of a positive charge by side-chain titration
that gives a stimulation of uptake over that seen at pHout
7.4. A second possibility is that the protein environment
surrounding H282 is such that its side chain pK is shifted
away from 6 and it is therefore always protonated, and
thus behaves more like an arginine or lysine. This effect
has been shown for example in the enzyme protein tyro-
sine kinase (Tishmack, Bashford, Harms, & Van Etten,
1997), where histidine residues had a pK as high as 9.2
when analysed by NMR.
In the original study on R282E-PepT1, it was
concluded that the uptake of peptide by the mutant trans-
porter was uncoupled from the movement of protons, and
that in addition to acting as a facilitated peptide trans-
porter, R282E-PepT1 also displayed a peptide-gated
non-specific cation conductance (Meredith, 2004). How-
ever, it is possible that this conclusion needs updating
in the light of the current findings that there are R282
mutants that, like R282E-PepT1, are not pH stimulated,
yet are still able to accumulate substrate above equi-
librium when an inwardly directed proton gradient is
imposed. For a transporter to be able to accumulate
substrate above equilibrium, an energy source must be
involved, in this case the proton electrochemical gra-
dient. Therefore, the mutant PepT1 proteins that can
accumulate substrate but do not show pH stimulation
(R282A and R282D) must still be coupled to the move-
ment of protons down their electrochemical gradient.
The lack of pH stimulation could be attributed to the
fact that during the transport cycle these specific mutants
have a different rate limiting step to the wild-type, and
that for these mutants that step is not pH dependent.
It has already been reported that R282E-PepT1 has a
faster rate of efflux than wild-type, consistent with an
uncoupling of peptide uptake from the proton driving
force (Meredith, 2004); the finding here that the rates
of efflux for the other R282 mutants are not differ-
ent from that of the wild-type is in agreement with
the hypothesis that they are still proton-coupled, as
shown by their ability to accumulate substrate above
the extracellular concentration at pHout 5.5 but not
7.4.
The simplest hypothesis was that in R282E-PepT1,
the extra inward charge movement associated with pep-
tide uptake collapsed the membrane potential, which
is known to be the major driving force for proton-
coupled peptide uptake (Temple & Boyd, 1998), hence
the apparent lack of substrate accumulation. Therefore
by extension one would expect R282D- and R282A-
PepT1 to have the same charge coupling as the wild-type,
as they too accumulate substrate, but this was not the
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ArrowFig. 9. Model for PepT1 substrate binding and translocation.
case: both R282E-, R282D- and R282A-PepT1 showed
the same increased charge:peptide apparent stoichiom-
etry, i.e. substantially larger than the wild-type. This
stoichiometry itself showed pH dependence, with a lower
value of around 2 for the mutants at pH 7.4, suggesting
that the current is either carried by protons or is a pH-
sensitive phenomenon. There was no difference in the
uptake in the absence or presence of sodium, either for
R282E-PepT1 (Meredith, 2004) or R282D-PepT1 (data
not shown).
The finding that the R282E/D341R- and R282D/
D341R-PepT1 double mutants (the latter being a charge
pair reversal of the naturally occurring residues in rab-
bit PepT1) had the same characteristics as the wild-type
protein strongly suggests that these two residues do inter-
act in the 3D protein (Pieri et al., 2004) as previouslys represent salt bridges or hydrogen bonds between residues.
proposed (Meredith, 2004). During the preparation of
this manuscript, Kulkarni et al. (2007) reported findings
consistent with R282 and D341 forming a charge pair
in human PepT1. The initial hypothesis that in R282E-
PepT1 repulsion between E282 and D341 allowed the
movement of extra ions through the protein when a pep-
tide is transported was not supported however by the
finding that the single D341R mutant also behaved like
the wild-type, as one might have thought that R282 and
R341 would repel in much the same way as E282 and
D341. That D341R-PepT1 behaved like wild-type sug-
gests that although R282 and D341 seem to form a
charge pair, in rabbit PepT1 residue 341 being negatively
charged is not crucial to PepT1 function; interestingly,
in human PepT1 the D341R single mutant had reduced
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ifference between rabbit and human PepT1 is not
lear. The observation that the non-transported PepT1
ubstrate 4-AMBA did not induce a depolarisation in
282E-PepT1-expressing oocytes clearly shows that the
harge movement is linked to substrate binding and
ranslocation and not to binding alone. One explanation
or the increase in proton–peptide stoichiometry is that
n wild-type PepT1 the presence of a positively charged
esidue deep in the binding pocket at position 282 repels
roton movement through the transporter protein during
he translocation step. The data in Fig. 6 are consistent
ith this, as the apparent stoichiometry is lower at pHout
.4 than it is at pHout 5.5, indicating that the proton
lectrochemical gradient is involved.
In the case of mutations where R282 was replaced
ith a non-positively charged amino acid, the rate-
imiting step of the transport cycle must be insensitive
o extracellular pH, hence the lack of stimulation when
he pHout is dropped from 7.4 to 5.5. Kinetic analysis
f peptide transport by PepT1 in rat renal brush border
embrane vesicles (Temple & Boyd, 1998) showed that
t pHout7.4/pHin7.4, it was the protonation of the carrier
rotein that was the rate-limiting step (Temple, Bailey,
ronk, & Boyd, 1996), whereas at pHout5.5/pHin7.4
t was the return of the unloaded carrier. The rate of
eptide uptake by R282E-PepT1 (corrected for protein
xpression in the intact oocyte plasma membrane by
uminometry, Panitsas et al., 2006) is the same as for
he wild-type at pHout 5.5 (data not shown), but, unlike
or the wild-type, is not slower at pHout 7.4. This indi-
ates that the mutations to arginine282 that abolish pH
ensitivity (R to E, D, A, or Q) are affecting the rate
imiting step, so when pHout is 7.4 the rate limiting step
as the same magnitude as that at pHout 5.5, hence the
ack of sensitivity to changing pHout. The rate limit-
ng protonation of the outward-facing carrier protein at
Hout 7.4, the first step in the transport cycle (Temple
t al., 1996), was proposed by us (Bailey et al., 2000;
eredith & Boyd, 1995) and others (e.g. Steel et al.,
997; Uchiyama, Kulkarni, Davies, & Lee, 2003) to be
rotonation of histidine57 (H57). In the R282-PepT1
utants, except for R282K and R282H, the lack of a pos-
tively charged residue might result in a conformational
hange of the protein that changes the local environment
nd increases the pKa of H57, such that it is more easily
rotonated at a higher pHout. Thus at pHout 7.4 the rate
imiting step is no longer the protonation of H57, but the
eturn of the unloaded carrier, as it is at pH 5.5, henceout
he similar transport rates at pHout 5.5 and 7.4.
A model for how proton–peptide transport might
ccur is shown in Fig. 9: the empty PepT1 is primed
y protonation of H57, followed by the binding of aemistry & Cell Biology 40 (2008) 721–730 729
zwitterionic peptide, with the N-terminal co-ordinated
at E595 and the C-terminal at H57-H+ (Meredith et al.,
2000). Although the binding of the substrate C-terminal
to His57-H+ is in disagreement with the conclusion of
Terada et al. (1998), it is supported by the finding that
N-Acetyl-Phe, a known PepT1 substrate which does not
have a free amino terminal (Meredith et al., 2000), can
protect PepT1 against inhibition by DEPC. Additionally,
the finding that significant DEPC inhibition is still evi-
dent when oocytes were co-incubated with the PepT1
substrate l-Ala-Tyramine which lacks a carboxyl termi-
nus further adds to the notion that H57-H+ binds the
carboxyl terminus of the substrate (Fig. 8). H57-H+ then
donates its proton to the C-terminal carboxyl group, and
the transporter undergoes a conformational change that
leads to the breaking of the salt bridge between R282 and
D341, re-orientating the binding site to be inward fac-
ing as simultaneously the protonated N-terminal of the
substrate binds to D341, neutralising the charge, and the
R282 charge is stabilised by Y167 (the chemical prop-
erties of this tyrosine have been shown to be essential,
Yeung et al., 1998). The peptide molecule is then released
into the cytoplasm, whereby it returns to the zwitterionic
state by releasing the proton from the carboxyl terminal.
The transporter then undergoes the reverse conforma-
tional change to re-orientate the binding site to outward
facing, and R282 reforms the salt bridge with D341.
As R282E-PepT1 cannot accumulate substrate, the
implication must be that the movement of peptide is no
longer coupled to the movement of the protons, whereas
in all the other mutants coupling must be maintained.
If for R282E-PepT1 the pKa of H57 was raised to the
point that it was no longer favourable for it to donate
its proton to the carboxyl terminus of the substrate, then
peptide transport would no longer be proton-coupled,
and this would explain the failure of R282E-PepT1 to
accumulate substrate. Intriguingly, it can be seen in Fig. 6
that both R282D- and R282A-PepT1 appear to carry
approximately one more charge per substrate peptide
than R282E-PepT1, which is consistent with the hypoth-
esis that one of the charges carried is coupled with the
substrate.
In conclusion, the arginine at position 282 in rabbit
PepT1 plays an intriguing role in the function of the
transporter, with mutations to different residues reveal-
ing that a positive residue is required for pH dependence,
whilst only R282E-PepT1 cannot concentrate substrate
above equilibrium; this is despite other mutations, most
notably R282D-PepT1, having a similarly increased
charge:peptide stoichiometry. As previously proposed,
R282 (TMD7) forms a charge pair with D341 (TMD8),
with R282E/D341R-PepT1 showing normal transport
f Bioch
Yeung, A. K., Basu, S. K., Wu, S. K., Chu, C., Okamoto, C. T., Hamm-730 M. Pieri et al. / The International Journal o
characteristics. Further biological testing or a crystal
structure of PepT1 will be required to establish the valid-
ity of the model proposed.
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